DS

Deepali Swapnil Pacharne

Active Director Director DIN 11792664
DIN 11792664 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepali Swapnil Pacharne

Deepali Swapnil Pacharne is a Director at Davaceutics Pharma Private Limited (since 2026).

DIN 11792664
Primary Designation Director
First Appointment 27 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Davaceutics Pharma Private Limited U86200PN2026PTC257113
Director27 Jun 20262026Active

Board colleagues of Deepali Swapnil Pacharne

NameDINCompanyDesignation
Swapnil Patilbuwa Pacharne07898480Davaceutics Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Davaceutics Pharma Private Limited
Premium access

Shareholding and investment profile for Deepali Swapnil Pacharne

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepali Swapnil Pacharne

Deepali Swapnil Pacharne currently holds 1 directorship: Davaceutics Pharma Private Limited (Director, since 27 Jun 2026).

Deepali Swapnil Pacharne was first appointed on 27 Jun 2026 as Director at Davaceutics Pharma Private Limited.

The current boards of Deepali Swapnil Pacharne's companies include Swapnil Patilbuwa Pacharne (Davaceutics Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available